A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Active Not Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase 2
- Study design
- NA · SINGLE GROUP · TREATMENT · NONE
- Evidence population
- Human clinical study registration
- Participants
- 96
- Population
- ALL · 18 Years to 44 Years
- Duration
- 2022-03-02 to 2027-03-01
- Intervention
- Metformin; Digital Intervention
- Comparator
- Not reported
- Outcomes measured
- Adherence for feasibility — 2 years; Digitally-delivered core education curriculum through the lifestyle change platform — At end of Week 24; Safety and Adverse Events (Symptom Log including monitoring for AEs) — Week 4; Safety and Adverse Events (Symptom Log including monitoring for AEs) — Week 8; Safety and Adverse Events (Symptom Log including monitoring for AEs) — Week 12; Safety and Adverse Events (Symptom Log including monitoring for AEs) — Week 14; Safety and Adverse Events (Symptom Log including monitoring for AEs) — Week 16; Safety and Adverse Events (Symptom Log including monitoring for AEs) — Week 20; Safety and Adverse Events (Symptom Log including monitoring for AEs) — Week 24; Drug adherence/Pill Counts — Week 2; Drug adherence/Pill Counts — Week 4; Drug adherence/Pill Counts — Week 8; Drug adherence/Pill Counts — Week 12; Drug adherence/Pill Counts — Week 16; Drug adherence/Pill Counts — Week 20; Drug adherence/Pill Counts — Week 24; Glycemic Control — Baseline to Week 24 (on campus labs at Baseline, Week 12 and 24); Glycemic Control — Baseline to Week 24 (on campus labs at Baseline, Week 12 and 24
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Metformin · 100%Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Summary supplies ageing or longevity context.
Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.